Trial Profile
Adalimumab in patients with active, noninfectious uveitis using high-dose corticosteroids.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Feb 2016
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Prednisone
- Indications Uveitis
- Focus Therapeutic Use
- 08 Feb 2016 New trial record